Cabot Wealth Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.1M Sell
26,548
-1,077
-4% -$497K 1.43% 27
2026
Q1
$13.3M Buy
27,625
+9,085
+49% +$4.65M 1.53% 23
2025
Q4
$10.4M Buy
18,540
+90
+0.5% +$51.1K 1.15% 33
2025
Q3
$9.49M Buy
18,450
+407
+2% +$178K 1.05% 39
2025
Q2
$5.66M Buy
18,043
+74
+0.4% +$22.2K 0.67% 48
2025
Q1
$5.47M Buy
17,969
+1,473
+9% +$495K 0.7% 47
2024
Q4
$5.48M Buy
16,496
+871
+6% +$295K 0.7% 48
2024
Q3
$5.22M Buy
15,625
+671
+4% +$255K 0.65% 48
2024
Q2
$6.16M Buy
14,954
+529
+4% +$209K 0.81% 44
2024
Q1
$5.83M Buy
+14,425
New +$5.07M 0.76% 42

Other funds holding MEDP

Cabot Wealth Management's MEDP Position: Q2 2026 in Review

Cabot Wealth Management reduced its Medpace (MEDP) stake by 3.9% in Q2 2026, selling an estimated $497K and leaving 26,548 shares worth $14.1M. The position accounts for 1.43% of the portfolio, ranked #27.

Cabot Wealth Management first reported a position in MEDP in Q1 2024 and has held it in 10 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Cabot Wealth Management held 26,548 shares of Medpace worth $14.1M as of Q2 2026.
  • Cabot Wealth Management sold 1,077 Medpace shares in Q2 2026, an estimated $497K.
  • Medpace made up 1.43% of Cabot Wealth Management's portfolio in Q2 2026, its #27 holding.
  • Cabot Wealth Management first reported a position in Medpace in Q1 2024 and has held it in 10 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Cabot Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.